BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38502293)

  • 1. Surgery for Oligometastatic Pancreatic Cancer: Defining Biologic Resectability.
    Koti S; Demyan L; Deutsch G; Weiss M
    Ann Surg Oncol; 2024 Jun; 31(6):4031-4041. PubMed ID: 38502293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oligometastatic pulmonary metastasis in pancreatic cancer patients: Safety and outcome of resection.
    Ilmer M; Schiergens TS; Renz BW; Schneider C; Sargut M; Waligora R; Weniger M; Hartwig W; Ceyhan GO; Friess H; Werner J; D'Haese JG
    Surg Oncol; 2019 Dec; 31():16-21. PubMed ID: 31473583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CT response of primary tumor and CA19-9 predict resectability of metastasized pancreatic cancer after FOLFIRINOX.
    Tanaka M; Heckler M; Mihaljevic AL; Sun H; Klaiber U; Heger U; Büchler MW; Hackert T
    Eur J Surg Oncol; 2019 Aug; 45(8):1453-1459. PubMed ID: 30981446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative evaluation of pancreatic ductal adenocarcinoma with synchronous liver metastasis: Diagnosis and assessment of unresectability.
    Shi HJ; Jin C; Fu DL
    World J Gastroenterol; 2016 Dec; 22(45):10024-10037. PubMed ID: 28018110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anatomical and Biological Considerations to Determine Resectability in Pancreatic Cancer.
    Rompen IF; Habib JR; Wolfgang CL; Javed AA
    Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgery or Locoregional Approaches for Hepatic Oligometastatic Pancreatic Cancer: Myth, Hope, or Reality?
    Ghidini M; Petrillo A; Salati M; Khakoo S; Varricchio A; Tomasello G; Grossi F; Petrelli F
    Cancers (Basel); 2019 Aug; 11(8):. PubMed ID: 31374916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is Oligometastatic Cancer Curable? A Survey of Oncologist Perspectives, Decision Making, and Communication.
    Cho HL; Balboni T; Christ SM; Turner B; Spektor A; Perni S
    Adv Radiat Oncol; 2023; 8(5):101221. PubMed ID: 37124028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of circulating-tumour DNA analysis by metastatic sites in pancreatic cancer.
    Umemoto K; Sunakawa Y; Ueno M; Furukawa M; Mizuno N; Sudo K; Kawamoto Y; Kajiwara T; Ohtsubo K; Okano N; Matsuhashi N; Itoh S; Matsumoto T; Shimizu S; Otsuru T; Hasegawa H; Okuyama H; Ohama H; Moriwaki T; Ohta T; Odegaard JI; Nakamura Y; Bando H; Yoshino T; Ikeda M; Morizane C
    Br J Cancer; 2023 Apr; 128(8):1603-1608. PubMed ID: 36782009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncologic resection of pancreatic cancer with isolated liver metastasis: Favorable outcomes in select patients.
    Nagai M; Wright MJ; Ding D; Thompson ED; Javed AA; Weiss MJ; Hruban RH; Yu J; Burkhart RA; He J; Cameron JL; Wolfgang CL; Burns WR
    J Hepatobiliary Pancreat Sci; 2023 Aug; 30(8):1025-1035. PubMed ID: 36652559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FDG-PET Predicts Neoadjuvant Therapy Response and Survival in Borderline Resectable/Locally Advanced Pancreatic Adenocarcinoma.
    Abdelrahman AM; Goenka AH; Alva-Ruiz R; Yonkus JA; Leiting JL; Graham RP; Merrell KW; Thiels CA; Hallemeier CL; Warner SG; Haddock MG; Grotz TE; Tran NH; Smoot RL; Ma WW; Cleary SP; McWilliams RR; Nagorney DM; Halfdanarson TR; Kendrick ML; Truty MJ
    J Natl Compr Canc Netw; 2022 Sep; 20(9):1023-1032.e3. PubMed ID: 36075389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Local Treatment for Oligometastasis: A Comparability-Based Meta-Analysis.
    Rim CH; Cho WK; Lee JH; Kim YS; Suh YG; Kim KH; Chie EK; Ahn YC;
    Cancer Res Treat; 2022 Oct; 54(4):953-969. PubMed ID: 35989655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Factors After Pancreatectomy for Pancreatic Cancer Initially Metastatic to the Liver.
    Frigerio I; Malleo G; de Pastena M; Deiro G; Surci N; Scopelliti F; Esposito A; Regi P; Giardino A; Allegrini V; Bassi C; Girelli R; Salvia R; Butturini G
    Ann Surg Oncol; 2022 Dec; 29(13):8503-8510. PubMed ID: 35976466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncological Outcome of Conversion Surgery After Preoperative Chemotherapy for Metastatic Pancreatic Cancer.
    Hank T; Klaiber U; Hinz U; Schütte D; Leonhardt CS; Bergmann F; Hackert T; Jäger D; Büchler MW; Strobel O
    Ann Surg; 2023 May; 277(5):e1089-e1098. PubMed ID: 35758505
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.